Skip to content

Author

Christopher P Seaman

We have 2 of 12 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Cost-effectiveness of the hepatitis B birth-dose vaccine in South Africa: a mathematical modelling analysis.

The findings support implementation of a universal HepB-BD policy alongside South Africa's current hepatitis B viral transmission elimination efforts and were modelled to be the most cost-effective option at a willingness-to-pay threshold of 0·5 × per-capita gross domestic product (ZAR 57 281).

Christopher P. Seaman, Christopher R. Bailie, C. Spearman et al. · 1 citation
Open access Jul 2026

Cost-benefit analysis of a potential hepatitis C vaccine: a modelling study.

In the context of heterogeneous treatment scale-up among countries, a hepatitis C vaccine is likely to have a positive return-on-investment when used to vaccinate populations at highest risk of infection.

Farah Houdroge, Phillip Luong, Jessica Zuk et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.